Codexis Inc. (NASDAQ: CDXS)
$4.9200
-0.3600 ( -6.46% ) 275.6K
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
Market Data
Open
$4.9200
Previous close
$5.2800
Volume
275.6K
Market cap
$400.38M
Day range
$4.8640 - $5.3960
52 week range
$2.5300 - $6.0800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Nov 12, 2024 |
3 | Insider transactions | 2 | Nov 12, 2024 |
4 | Insider transactions | 1 | Nov 12, 2024 |
8-k | 8K-related | 15 | Oct 31, 2024 |
10-q | Quarterly Reports | 84 | Oct 31, 2024 |
4 | Insider transactions | 1 | Oct 28, 2024 |
8-k | 8K-related | 13 | Oct 22, 2024 |
4 | Insider transactions | 2 | Oct 10, 2024 |
4 | Insider transactions | 1 | Oct 10, 2024 |
3 | Insider transactions | 2 | Oct 10, 2024 |